151 related articles for article (PubMed ID: 24334751)
21. Follow-up testing of rodent carcinogens not positive in the standard genotoxicity testing battery: IWGT workgroup report.
Kasper P; Uno Y; Mauthe R; Asano N; Douglas G; Matthews E; Moore M; Mueller L; Nakajima M; Singer T; Speit G;
Mutat Res; 2007 Feb; 627(1):106-16. PubMed ID: 17123861
[TBL] [Abstract][Full Text] [Related]
22. Need and potential value of the Pig-ain vivo mutation assay-a HESI perspective.
Schuler M; Gollapudi BB; Thybaud V; Kim JH
Environ Mol Mutagen; 2011 Dec; 52(9):685-9. PubMed ID: 21976154
[TBL] [Abstract][Full Text] [Related]
23. Genetic toxicity assessment: employing the best science for human safety evaluation part IV: Recommendation of a working group of the Gesellschaft fuer Umwelt-Mutationsforschung (GUM) for a simple and straightforward approach to genotoxicity testing.
Pfuhler S; Albertini S; Fautz R; Herbold B; Madle S; Utesch D; Poth A;
Toxicol Sci; 2007 Jun; 97(2):237-40. PubMed ID: 17303579
[TBL] [Abstract][Full Text] [Related]
24. Genetic toxicity assessment: employing the best science for human safety evaluation Part VII: Why not start with a single test: a transformational alternative to genotoxicity hazard and risk assessment.
Ku WW; Aubrecht J; Mauthe RJ; Schiestl RH; Fornace AJ
Toxicol Sci; 2007 Sep; 99(1):20-5. PubMed ID: 17548889
[TBL] [Abstract][Full Text] [Related]
25. Use of genetic toxicology information for risk assessment.
Dearfield KL; Moore MM
Environ Mol Mutagen; 2005 Dec; 46(4):236-45. PubMed ID: 16258925
[TBL] [Abstract][Full Text] [Related]
26. Assessment of the sensitivity of the computational programs DEREK, TOPKAT, and MCASE in the prediction of the genotoxicity of pharmaceutical molecules.
Snyder RD; Pearl GS; Mandakas G; Choy WN; Goodsaid F; Rosenblum IY
Environ Mol Mutagen; 2004; 43(3):143-58. PubMed ID: 15065202
[TBL] [Abstract][Full Text] [Related]
27. Way forward in case of a false positive in vitro genotoxicity result for a cosmetic substance?
Doktorova TY; Ates G; Vinken M; Vanhaecke T; Rogiers V
Toxicol In Vitro; 2014 Feb; 28(1):54-9. PubMed ID: 24095862
[TBL] [Abstract][Full Text] [Related]
28. Application of toxicogenomics to study mechanisms of genotoxicity and carcinogenicity.
Ellinger-Ziegelbauer H; Aubrecht J; Kleinjans JC; Ahr HJ
Toxicol Lett; 2009 Apr; 186(1):36-44. PubMed ID: 18822359
[TBL] [Abstract][Full Text] [Related]
29. Next Generation Sequencing Workshop at the Royal Society of Medicine (London, May 2022): how genomics is on the path to modernizing genetic toxicology.
Lynch AM; Zanoni TB; Salk JJ; Martincorena I; Young RR; Kucab J; Valentine CC; Yauk C; Escobar PA; Witt KL; Frötschl R; Reed SH; Ashford A
Mutagenesis; 2023 Aug; 38(4):192-200. PubMed ID: 37300447
[TBL] [Abstract][Full Text] [Related]
30. Computational systems biology and dose-response modeling in relation to new directions in toxicity testing.
Zhang Q; Bhattacharya S; Andersen ME; Conolly RB
J Toxicol Environ Health B Crit Rev; 2010 Feb; 13(2-4):253-76. PubMed ID: 20574901
[TBL] [Abstract][Full Text] [Related]
31. Factors to consider in the use of stem cells for pharmaceutic drug development and for chemical safety assessment.
Trosko JE; Chang CC
Toxicology; 2010 Mar; 270(1):18-34. PubMed ID: 19948204
[TBL] [Abstract][Full Text] [Related]
32. Genetic toxicity assessment: employing the best science for human safety evaluation part VI: when salt and sugar and vegetables are positive, how can genotoxicity data serve to inform risk assessment?
Pottenger LH; Bus JS; Gollapudi BB
Toxicol Sci; 2007 Aug; 98(2):327-31. PubMed ID: 17387098
[TBL] [Abstract][Full Text] [Related]
33. Toxicity testing in the 21st century: implications for human health risk assessment.
Krewski D; Andersen ME; Mantus E; Zeise L
Risk Anal; 2009 Apr; 29(4):474-9. PubMed ID: 19144067
[TBL] [Abstract][Full Text] [Related]
34. Gene expression profile analysis: an emerging approach to investigate mechanisms of genotoxicity.
Aubrecht J; Caba E
Pharmacogenomics; 2005 Jun; 6(4):419-28. PubMed ID: 16004560
[TBL] [Abstract][Full Text] [Related]
35. The embryonic stem cell test combined with toxicogenomics as an alternative testing model for the assessment of developmental toxicity.
van Dartel DA; Piersma AH
Reprod Toxicol; 2011 Sep; 32(2):235-44. PubMed ID: 21575713
[TBL] [Abstract][Full Text] [Related]
36. Computational toxicology: heading toward more relevance in drug discovery and development.
Johnson DE; Rodgers AD
Curr Opin Drug Discov Devel; 2006 Jan; 9(1):29-37. PubMed ID: 16445115
[TBL] [Abstract][Full Text] [Related]
37. Comparative overview of current international strategies and guidelines for genetic toxicology testing for regulatory purposes.
Cimino MC
Environ Mol Mutagen; 2006 Jun; 47(5):362-90. PubMed ID: 16649190
[TBL] [Abstract][Full Text] [Related]
38. Toxicology in the 21st century--working our way towards a visionary reality.
Berg N; De Wever B; Fuchs HW; Gaca M; Krul C; Roggen EL
Toxicol In Vitro; 2011 Jun; 25(4):874-81. PubMed ID: 21338664
[TBL] [Abstract][Full Text] [Related]
39. Toxicogenomics for the prediction of toxicity related to herbs from traditional Chinese medicine.
Youns M; Hoheisel JD; Efferth T
Planta Med; 2010 Dec; 76(17):2019-25. PubMed ID: 20957595
[TBL] [Abstract][Full Text] [Related]
40. Stem cell models for drug discovery and toxicology studies.
Liu W; Deng Y; Liu Y; Gong W; Deng W
J Biochem Mol Toxicol; 2013 Jan; 27(1):17-27. PubMed ID: 23293059
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
